Surgery Partners (NASDAQ:SGRY) Stock Rating Reaffirmed by Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Surgery Partners (NASDAQ:SGRY) in a report issued on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $43.00 price objective on the stock.

Other equities analysts also recently issued reports about the company. StockNews.com upgraded Surgery Partners from a sell rating to a hold rating in a research note on Thursday, March 21st. Benchmark restated a buy rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Wednesday, May 1st. Citigroup decreased their target price on Surgery Partners from $42.00 to $38.00 and set a buy rating for the company in a research note on Wednesday, May 8th. Finally, Macquarie started coverage on Surgery Partners in a research note on Friday, June 28th. They issued an outperform rating and a $31.00 target price for the company. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of Moderate Buy and an average price target of $40.14.

Surgery Partners Stock Up 5.2 %

NASDAQ:SGRY opened at $26.87 on Tuesday. The company has a market capitalization of $3.41 billion, a price-to-earnings ratio of 29.71, a price-to-earnings-growth ratio of 1.94 and a beta of 2.78. Surgery Partners has a one year low of $22.05 and a one year high of $44.88. The stock has a 50-day simple moving average of $25.30 and a 200 day simple moving average of $28.29. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.56 and a current ratio of 1.71.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. The business had revenue of $717.40 million during the quarter, compared to the consensus estimate of $707.66 million. Sell-side analysts predict that Surgery Partners will post 0.88 EPS for the current fiscal year.

Insider Activity

In related news, insider Danielle Burkhalter sold 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $26.39, for a total transaction of $158,340.00. Following the sale, the insider now owns 30,354 shares of the company’s stock, valued at $801,042.06. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 2.30% of the company’s stock.

Institutional Investors Weigh In On Surgery Partners

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Mesirow Institutional Investment Management Inc. raised its holdings in Surgery Partners by 12.4% during the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock worth $108,000 after purchasing an additional 373 shares in the last quarter. Natixis Advisors L.P. increased its holdings in shares of Surgery Partners by 8.6% in the fourth quarter. Natixis Advisors L.P. now owns 11,735 shares of the company’s stock valued at $375,000 after buying an additional 934 shares in the last quarter. ProShare Advisors LLC increased its holdings in shares of Surgery Partners by 7.8% in the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after buying an additional 986 shares in the last quarter. DekaBank Deutsche Girozentrale increased its holdings in shares of Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares in the last quarter. Finally, Principal Financial Group Inc. increased its holdings in shares of Surgery Partners by 16.3% in the first quarter. Principal Financial Group Inc. now owns 10,073 shares of the company’s stock valued at $300,000 after buying an additional 1,409 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.